Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don't hate the players hate the game..
Isn't that what they say?...
It’s the same players everywhere you go.
That sure would be nice to get on the front end but then if you knew something the average Joe didn't they could take it all away from you
I really wanna start getting on the front end of some of these pump and dumps. There’s gotta be a way to do it.
Did you see are old Skymark research play sold as a shell company and it looks like they might be a marijuana stock pbec..
Dude... glad to hear from somebody over here..
Going good, hope you been all right..
Bronson how’s it going man!!
What's up snack
$ARYC Silicon Valley biotech stock Arrayit Corporation.
Due Diligence link:
https://cdn.discordapp.com/attachments/357369664193560596/459932549062590475/Arrayit_Due_Diligence_Report_.pdf
Arrayit Corporation Reports Clinical Instrumentation Sale to the FDA
Sunnyvale, July 16, 2018 (GLOBE NEWSWIRE) -- July 16, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State of California Department of Public Health (CDPH). The instrumentation reads and reports test results for the company’s allergy and dietary wellness tests and pipeline tests for ovarian cancer and Parkinson’s Disease (PD).
Arrayit recently scored 100% on immunoglobulin E (IgE) proficiency testing with the College of American Pathologists, announced a nationwide sales network of 1,700 professional sales representatives to sell and distribute the company’s finger stick tests, and completed pilot testing with one the nation’s largest chains of retail stores. Arrayit microarray tests conveniently use a few drops of blood collected on a blood card to assist doctors in identifying and treating allergy, asthma, dietary intolerance and pipeline indications for ovarian cancer and PD. The company recently met with top officials at the FDA to discuss FDA approval of a major product line. The FDA ensures the safety of food, drugs and medical devices by regulating consumer products exceeding $1,000,000,000,000 ($1 trillion) in annual revenues.
Arrayit CEO Rene Schena states, “The sale of clinical instrumentation to the FDA advances our personalized medicine initiatives by strengthening ties with the nation’s preeminent regulatory agency. Our transformative healthcare products and services benefit from transparency in the hands of top FDA scientists.”
https://www.nasdaq.com/press-release/arrayit-corporation-reports-clinical-instrumentation-sale-to-the-united-states-food-and-drug-20180716-00167
August 13, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved for in-store allergy testing promotions by a major United States retailer. Arrayit sales and marketing experts will conduct allergy test promotions in-store, and medical professionals at in-store clinics will collect finger stick blood specimens. Two thousand retail locations nationwide averaging 3,000 customer visits per store per day would give Arrayit access to 6 million retail customers daily, creating the potential for exponential sales growth. This promotional campaign required rigorous vetting and high-level corporate approval by the retailer, which reports revenues exceeding $50 billion annually.
Arrayit recently completed an allergy testing pilot program for a retail chain, established a nationwide network of 1,700 sales professionals to sell and distribute the company’s finger stick microarray tests, met with top officials at the United States Food and Drug Administration (FDA) regarding FDA approval of a major product line, reported the sale of clinical instrumentation to the FDA, and signed allergy testing contracts with a consortium of 178 medical clinics. Doctors can use allergy test results as a guide to prescribe allergy medicines, immunotherapy, food elimination and lifestyle changes. The availability of allergy medicines and immunotherapy products at retail stores, allows customers to incorporate an allergy test into a convenient family shopping experience.
https://www.yahoo.com/amphtml/finance/news/arrayit-corporation-receives-approval-store-093000820.html
August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces allergy testing partnerships with multiple providers of allergen immunotherapy products including sub-cutaneous, sublingual, and oral allergy medicines designed to treat patients of allergy and asthma. Allergen immunotherapy, a time-tested clinical approach, can reduce or eliminate allergy and asthma symptoms by lowering the levels of specific cellular proteins known as immunoglobulin E (IgE) molecules that activate the immune system and trigger immune responses. Through these partnerships, doctors prescribing Arrayit allergy tests gain access to a portfolio of safe, effective and convenient allergy medicines for their allergy and asthma patients, including custom immunotherapy products formulated upon review of quantitative allergy test results.
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding FDA approval of a major product line, reported the sale of clinical instrumentation to the FDA, signed allergy testing contracts with a consortium of 178 medical clinics and received approval for in-store promotions by a major retailer. Arrayit’s new therapeutics partners provide a seamless solution to doctors who diagnose and treat the more than 50 million Americans reporting allergic symptoms annually.
https://www.yahoo.com/amphtml/finance/news/arrayit-corporation-announces-allergy-testing-093000949.html
I’m Back! Who got rich on ACAD like I did?
The golden cross is a chart pattern created when a shorter term moving average was below a longer term moving average, but it crosses above that moving average. This is typically seen as a bullish signal.
The golden cross is mostly used with longer term moving averages. It's an especially strong signal when the 50 day moving average crosses above the 200 day moving average.
http://www.trade-ideas.com/Glossary/Golden_Cross.html
http://stockcharts.com/h-sc/ui?s=ADMD&p=D...9037239325
do you still have that old video of the guy in school getting up and slapping the other guy?
Some one is driving around in snacks old car,
even put a pic up in there I box.
http://investorshub.advfn.com/STOCKS-OF-SILVER-22271/
Hey Bronson. Just grabbed 100K at .0038 would like to see a run back up over .01
Thanks I took some of the $ and ran just playing with profits now. hoping this run will keep on for a few only 29 mill float very tight if there not screwing around.
Damn, nice run on DKAM! Congrats man!
doing real well over in $DKAM land
good luck on your $NMRX
Glad your keeping busy.
Hey Bronson! Hope you're doing well. I haven't been on the hub much let alone the Snack board...
Currently in NMRX and supposed to get a decent penny play later this week. I'll share with the board if anyone is interested. Haven't been doing too much trading lately though, just focusing on work and school.
Nice your getting some sleep. I don't know how you keep the schedule you do without it.
Sorry about the wife's dad.
Keep in touch. :)
We are doing well. Youngest is about 6 months old and cutting two teeth. Starting to sleep through the night, finally.
My wife's dad has been pretty sick recently and we have been having to deal with that. He lives near us and really close to our kids.
Haven't actually traded at all since last year. I think I got a little burned out. I will get back into it soon. I will let you know.
Nice...let me know if you find out anything about that.
I could use the money. :)
Been some time...hope all is well with you and your family.
Not a bad article explaining Cash-secured Put selling....
www.ifii.com/articles/644211472/how-to-buy-apple-below
When will I be able to buy this company as a shell and really get this squeegee business off the ground??? There was soo much potential!
Squeegee fo sheezee!
congratulations,
another 20 or 25 years you should be able to sleep good again.
What I found interesting is this paragraph...
Hmmm...thank's I'll take a look!
Yeah remember those days! Glad your getting it worked out.
I used to play that game, sounds fun!
nothing much. Just trying to get through this newborn phase without killing someone. We started extinguishing his nighttime feeding a week ago, because he was killing us. Getting more sleep now.
Bought the new Simcity game for the PC. Pretty good. You can play multiplayer.
$RVPL, you're welcome.
Check out the link. Pretty cool...
www.theblaze.com/stories/see-the-10-craziest-coolest-zaniest-most-seizure-inducing-christmas-light-shows-of-2012/
Yeah I was thinking about doing that butterfly mainly because I didn't understand the other two lol.
Happy holidays to you and your family!
I agree that AAPL is at a well tested support level.
Personally, I think that the fiscal cliff saga is not going to be settled going into the NewYear and all stocks are going to tank. I hope I am wrong. I am staying out of options right now anyway because of this mess and with the Holidays coming up, I can't pay as much attention as I would like.
With that being said, Since IV is so high, it is definitely preferable to open up a Net Negative VEGA strategy. Both the Iron Condor and Directional Butterfly fit this mold.
At this point, I would more likely open the Butterfly, since it expose less capital to risk.
I would definitely not do the reverse Calendar. It is a negative VEGA trade, but as he discussed, it takes a lot more margin to garner similar absolute returns.
3 trade ideas in AAPL - Friday close $533
The personality of AAPL has changed quite a bit in the last 2½ months. The stock is currently at $533, down 24% from its September 19 close of $702. During that same period, implied volatility has skyrocketed! Comparing at-the-money calls approximately 30 days from expiration, IV was 24 September 19 and today is currently at 39! Is it time to yell, "Sell Mortimer, Sell!" As in life as well as options, you can't have your cake and eat it too! Implied volatility levels have exploded because the stock has declined and gyrated wildly with much speed. That is the key, implied volatility acts up much more when there is speed, especially on the downside. I think there may be a few opportunities in AAPL options depending on your price and implied volatility outlook over the next month.
Opinion #1: I think AAPL has found a bottom here and the stock will be a little less volatile and more range bound going into the holidays.
Strategy: Iron Condor - Buy 1 January 600 call, and Sell 1 January 570 call, then Buy 1 January 490 put and Sell 1 January 520 put. The total credit is $16.50 ($1650) while the total risk is $13.50 ($1350).
Rationale: If the IV decreases 2 points over the next 16 days, the price range, within 1 standard deviation would be roughly $503-$590. Within this range we could make anywhere from 2% to over 25% on our risk or margin. Outside of this range exit the trade for a small loss or adjust it. I would look to be out of this trade in 14-16 days looking for about 10-12% profit target. If the price moves under $503 or over $590, I would exit and live to play another day.
Opinion #2: I think the stock will rally into January earnings!
Strategy: Bullish Call Butterfly - Buy 1 January 560 call and Sell 2 January 580 calls, then Buy 1 January 600 call. The total debit is $2 ($200). The maximum loss is limited to cost of the butterfly, $200. The profit potential could reach over $1600 if we landed at the short strike of $580 on the January expiration.
Rationale: If I think the stock can rally into earnings, January implied volatility will decrease and this butterfly will really expand. During the life of the butterfly, we can get a very wide profit area. However, as we get towards expiration, it narrows. If the IV decreases even 1 point over the next 20 days, the butterfly can make between 20-70% between $540 and $627, excluding commissions. This is an extremely wide range. My plan would be to hold it no longer than 20 days and look for at least a 30% profit on my initial cost.
Second Strategy for opinion #2: Reverse Calendar - Buy 1 January weekly $535 call that expires on January 4 and sell 1 January $535 call, expiring January 18. The total credit is $5.20. I would only do this in a portfolio margin account, since in a normal Reg. T account the excessive margin requirement makes this trade much less desirable.
Rationale: This is similar to a long straddle in that we would make money if the stock moved away from the short $535 strike in either direction. The difference versus a long straddle is that we would benefit if the implied volatility decreased, which would probably happen on the upside. What we don't want to happen is for the stock to hang around the short strike of $533, since it loses money. The way I would trade this is to take off the trade if it moves $30 in either direction. This is a more advanced speculative strategy and again, I would only trade this in a portfolio margin account.
The suggestion above uses the closing middle price between the Friday bid and ask. Monday, the option prices will be somewhat different due to the time decay over the weekend and any price change.
Cool, I'm going to paper trade around that Max Pain level see if I can get a system down.
MMs are always delta neutralizing their positions....usually with long stock.
Hey you think there is any value to this???
http://www.maximum-pain.com/max-pain.aspx
Max pain theory ays that the option writers will hedge the contracts they have written. In the case of the market maker, the hedging is done to remain neutral in the stock. Consider the market makers position if he must write an option contract without wanting a position in the stock. As the maturity date approaches, the stock price changes. In addition, contracts may be closed by the option buyers. As a result the option writer must rebalance his hedges. This rebalancing is an effort to hedge the open contracts, thus maintaining a state where the least amount of money will be paid out. Rebalancing of positions in the stock provide pressure on the price to close at the max pain point.
Interesting...
Thanks for that info.
Not sure how to take it. Could be good and bad. Good in the fact that it will make options trading more accessible to people, and better to able to perfectly hedge positions if that is what you use them for. Bad in the fact that it might bring down the Daily Volume and Open Interest on the 100 lot "classic" options on these securities, so it could widen the bid/ask on the strikes.
All of those securities are highly liquid anyway, so I can't imagine it would be that big a deal on the bid/ask.
Mini Options coming soon...
http://www.optioncast.com/options-news/mini-options-coming-march-18/
Yeah I hear ya. I haven't been too active either really, just monitoring my 401k and trying to figure out options trading. I am holding some LNDC long term, should have a good 2013.
Happy holidays to you as well!
Hey Fossil
Not sure yet if I want to get that in to it again, once a trader always a trader. To sit and day trade its too much right now for me. I keep an eye on a few things still, just not as much.
I will be watching the silver or SLV until the Fiscal Cliff is resolved, then look for the door or the ZSL ...imo
Happy Holiday Season,
Bronson
http://www.kitco.com/images/live/nysilver.gif
http://investorshub.advfn.com/iShares-Silver-Trust-SLV-5630/
http://investorshub.advfn.com/ProShares-Ultra-Short-Silver-ZSL-15829/
What's up Bronson! Getting back into the "trading season"?
looks like Kitco is messed up,
found another chart and it puts copper back in the 3.40s a #
http://www.livecharts.co.uk/MarketCharts/copper.php
http://www.kitcometals.com/charts/copper.html
Followers
|
12
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2846
|
Created
|
11/02/10
|
Type
|
Free
|
Moderator Lord DarkHelmet | |||
Assistants ryanmnly Fossil-Fuel BRONSON lonestar44 |
SNACK info board
Where anything goes....errr...as long as it doesn't get deleted by the Admin and you get thrown in jail...
Don't forget to bring your favorite snacks...
and your favorite drink....
If you have ever been a bagholder and are still bitter about it...then you can stop looking for friends...here we are.
investorshub.advfn.com/boards/read_msg.aspx
We also highly recommend this forum for even greater detailed information about some "plays" were are currently positioned in...
investorshub.advfn.com/boards/board.aspx
If you are going to whine too much though....perhaps this forum is better for you...
investorshub.advfn.com/boards/board.aspx
Posts Today
|
0
|
Posts (Total)
|
2846
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |